GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » EV-to-Revenue

Dabomb Protein Biotech (ROCO:6578) EV-to-Revenue : 4.64 (As of Apr. 29, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Dabomb Protein Biotech's enterprise value is NT$1,781.9 Mil. Dabomb Protein Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was NT$384.4 Mil. Therefore, Dabomb Protein Biotech's EV-to-Revenue for today is 4.64.

The historical rank and industry rank for Dabomb Protein Biotech's EV-to-Revenue or its related term are showing as below:

ROCO:6578' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.68   Med: 1.11   Max: 7.47
Current: 4.64

During the past 11 years, the highest EV-to-Revenue of Dabomb Protein Biotech was 7.47. The lowest was 0.68. And the median was 1.11.

ROCO:6578's EV-to-Revenue is ranked worse than
87.6% of 1871 companies
in the Consumer Packaged Goods industry
Industry Median: 1.14 vs ROCO:6578: 4.64

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-29), Dabomb Protein Biotech's stock price is NT$28.10. Dabomb Protein Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$7.42. Therefore, Dabomb Protein Biotech's PS Ratio for today is 3.79.


Dabomb Protein Biotech EV-to-Revenue Historical Data

The historical data trend for Dabomb Protein Biotech's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech EV-to-Revenue Chart

Dabomb Protein Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.02 1.02 1.97 2.08 3.22

Dabomb Protein Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.08 2.31 2.74 2.63 3.22

Competitive Comparison of Dabomb Protein Biotech's EV-to-Revenue

For the Packaged Foods subindustry, Dabomb Protein Biotech's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dabomb Protein Biotech's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dabomb Protein Biotech's EV-to-Revenue falls into.



Dabomb Protein Biotech EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Dabomb Protein Biotech's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1781.942/384.413
=4.64

Dabomb Protein Biotech's current Enterprise Value is NT$1,781.9 Mil.
Dabomb Protein Biotech's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$384.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dabomb Protein Biotech  (ROCO:6578) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Dabomb Protein Biotech's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=28.10/7.415
=3.79

Dabomb Protein Biotech's share price for today is NT$28.10.
Dabomb Protein Biotech's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$7.42.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dabomb Protein Biotech EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dabomb Protein Biotech (ROCO:6578) Business Description

Traded in Other Exchanges
N/A
Address
Number 52, Gongye 3rd Road, Annan District, Tainan, TWN, 709
Dabomb Protein Biotech Corp is a company specializing in antibiotic alternatives, and use postbiotics to boost immune strength and excel in innovative fermentation for improved plant protein utility. Their portfolio of products which include DBT-100 LS and DBT-100 HT , Liqui-TIDE bandage and LACTOTIDES HEALTH A+.

Dabomb Protein Biotech (ROCO:6578) Headlines

No Headlines